JDD Webinars

Recognizing the Role of The Sebaceous Gland in Acne

By October 6, 2020April 22nd, 2021No Comments

Featured Article

Recognizing The Role of the Sebaceous Gland in Acne

The Role of Androgen Receptors in the Development and Management of Acne Vulgaris

Androgen and androgen receptor (AR) may play important roles in several skin related diseases including androgenetic alopecia and acne vulgaris and recent studies suggest AR and androgens play distinct roles in the skin pathogenesis, and AR seems to be a better target than androgens for the treatment of these skin diseases.

Tune in as Leon H. Kircik, MD and James Q. Del Rosso, DO, FAOCD, FAAD discuss the mechanisms by which androgen/AR regulate sebocyte activity in acne vulgaris, and how suppressing AR function by treating with antiandrogens alone, or in combination with antibiotics (i.e., to reduce bacterial infection) might be a potential therapeutic approach to treat acne more effectively.

The results of this open-label clinical study suggest that a topical cream containing retinol 0.5% in combination with niacinamide, resveratrol, and hexylresorcinol is efficacious and tolerable for skin brightening/anti-aging when used with a complementary skin care regimen including SPF 30 sun protection.

Faculty


Leon H. Kircik, MD

Clinical Professor of Dermatology
Indiana University School of Medicine
Mount Sinai Medical Center, New York, NY
Physicians Skin Care, PLLC
Louisville, KY


James Q. Del Rosso, DO, FAOCD, FAAD

Research Director & Principal Investigator
JDR Dermatology Research
Thomas Dermatology
Las Vegas, Nevada

You May Also Like

Journal of Drugs in Dermatology JDD Article about Disparities in Hidradentitis Suppurativa Clinical Trials: An Updated Review of ClinicalTrials.gov from 2020 to 2024

Disparities in Hidradentitis Suppurativa Clinical Trials: An Updated Review of ClinicalTrials.gov from 2020 to 2024

| Featured Articles, Hidradenitis Suppurativa, Latest News, Skin of Color | No Comments
Representation improving but not solved—Black patients still underrepresented in recent HS trials A review of ClinicalTrials.gov trials for hidradenitis suppurativa initiated between June 2020 and December 2024 identified five trials…
Journal of Drugs in Dermatology JDD Article about Resolution of Lichen Simplex Chronicus With Nemolizumab: A Case Report

Resolution of Lichen Simplex Chronicus With Nemolizumab: A Case Report

| Case Reports, Featured Articles, Latest News | No Comments
Case report: IL‑31 receptor blockade markedly reduced neuropathic pruritus and improved quality of life in a 52‑year‑old woman after standard therapies failed Scarring reflects replacement of normal dermis by fibroblast-driven,…
Journal of Drugs in Dermatology JDD featuring Dr. Jacob Beer in JDD Re:View, a discussion of JDD articles and specific topics. This article highlights navigating the New Dermatology Landscape: Billing, Virtual Care, and the Rise of DermTok.

JDD Re:View With Dr. Beer

| Featured Articles, JDD Re:View, Latest News | No Comments
Navigating the New Dermatology Landscape: Billing, Virtual Care, and the Rise of DermTok In the past several years, managing and running a dermatology practice has changed drastically. These changes have…

Leave a Reply